Neurofilament light chain is a promising noninvasive biomarker for multiple sclerosis (MS), but lacks disease specificity due to other neurological causes. Apolipoprotein levels are negatively ...

Multiple sclerosis (MS) exhibits a notable seasonal pattern in both clinical expression and underlying pathophysiology. The interplay between environmental factors and immune regulation underpins ...

More research is necessary to understand cerebral oxygen consumption as a predictive biomarker for brain atrophy in multiple sclerosis (MS); however, this study found that mitochondrial dysfunction ...

Multiple sclerosis (MS) is driven by a complex interplay of adaptive and innate immune processes that breach central nervous system (CNS) immune privilege. Autoreactive CD4+ T cells, notably T helper ...

Multiple sclerosis, or MS, is a disease of the central nervous system that can cause symptoms throughout the body. The term “multiple sclerosis” refers to the multiple areas of scar tissue — often ...

Some research suggests that people with multiple sclerosis are at a higher risk of atherosclerosis. An increased risk hasn’t been established, and we don’t know how MS might increase the risk. Having ...

In a recent study published in Translational Psychiatr y, researchers pursued insights into the pathophysiological mechanisms governing neuropsychiatric symptoms of multiple sclerosis (MS). The study ...

People with multiple sclerosis (MS) have compromised immune systems. Certain disease-modifying therapies (DMTs) used for treating MS may weaken and make changes to the immune system. MS is an ...

Constipation having bowel movements less often than usual or stools that are hard or difficult to pass can affect how you feel throughout your day, disrupt routines, and make other multiple sclerosis ...